Total Payments
$5,682
2020 Payments
$345.33
Companies
22
Transactions
290
Medicare Patients
1,221
Medicare Billing
$163,156
Payment Breakdown by Category
Food & Beverage$5,657 (99.6%)
Education$24.69 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,657 | 286 | 99.6% |
| Education | $24.69 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,194 | 43 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $793.69 | 25 | $0 (2020) |
| Novo Nordisk Inc | $648.69 | 37 | $0 (2020) |
| GlaxoSmithKline, LLC. | $480.30 | 46 | $0 (2019) |
| Lilly USA, LLC | $447.21 | 24 | $0 (2018) |
| PFIZER INC. | $388.10 | 13 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $376.71 | 33 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $357.55 | 19 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $354.46 | 11 | $0 (2020) |
| Amgen Inc. | $181.37 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $345.33 | 16 | Janssen Pharmaceuticals, Inc ($106.55) |
| 2019 | $1,306 | 76 | Novo Nordisk Inc ($341.56) |
| 2018 | $2,429 | 109 | AstraZeneca Pharmaceuticals LP ($502.18) |
| 2017 | $1,603 | 89 | AstraZeneca Pharmaceuticals LP ($490.65) |
All Payment Transactions
290 individual payment records from CMS Open Payments — Page 11 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/27/2017 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: Diabetes | ||||||
| 06/26/2017 | Merck Sharp & Dohme Corporation | ZOSTAVAX (Biological), PNEUMOVAX 23, GARDASIL9 | Food and Beverage | In-kind items and services | $1.77 | General |
| Category: VACCINE | ||||||
| 06/21/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/20/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/14/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/13/2017 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $91.49 | General |
| 06/06/2017 | Novo Nordisk Inc | Levemir (Drug), Tresiba, Victoza | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: Diabetes | ||||||
| 06/05/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Diabetes | ||||||
| 06/01/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $8.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/22/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/22/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/11/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Diabetes | ||||||
| 05/09/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: RESPIRATORY | ||||||
| 05/04/2017 | Merck Sharp & Dohme Corporation | ASMANEX (Drug), BELSOMRA, DULERA | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: RESPIRATORY | ||||||
| 05/02/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/27/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $10.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/27/2017 | Lilly USA, LLC | HUMALOG (Drug), TRADJENTA, TRULICITY | Food and Beverage | In-kind items and services | $4.56 | General |
| Category: Diabetes | ||||||
| 04/26/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: Central Nervous System (CNS) | ||||||
| 04/24/2017 | Novo Nordisk Inc | Levemir (Drug), Tresiba, Victoza | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Diabetes | ||||||
| 04/19/2017 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.51 | General |
| 04/18/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Endocrinology | ||||||
| 04/17/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: RESPIRATORY | ||||||
| 04/13/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $112.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/12/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 226 | 330 | $92,860 | $26,764 |
| 2022 | 6 | 336 | 548 | $150,670 | $46,413 |
| 2021 | 5 | 287 | 549 | $145,659 | $46,605 |
| 2020 | 6 | 372 | 631 | $171,450 | $43,375 |
Total Patients
1,221
Total Services
2,058
Medicare Billing
$163,156
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 170 | 274 | $78,090 | $21,036 | 26.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 35 | 35 | $10,675 | $4,445 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 21 | $4,095 | $1,282 | 31.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 212 | 417 | $118,845 | $33,302 | 28.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 44 | 44 | $13,420 | $5,879 | 43.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 13 | 15 | $9,090 | $3,419 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 38 | $7,410 | $2,210 | 29.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 15 | 15 | $1,050 | $1,028 | 97.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 19 | 19 | $855.00 | $573.31 | 67.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 213 | 472 | $134,520 | $41,841 | 31.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 19 | 19 | $5,795 | $2,614 | 45.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 21 | $4,095 | $1,299 | 31.7% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 18 | 18 | $766.44 | $519.84 | 67.8% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 19 | 19 | $482.79 | $330.79 | 68.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 260 | 516 | $147,060 | $36,121 | 24.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 37 | 37 | $11,285 | $3,967 | 35.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 28 | $5,460 | $1,334 | 24.4% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 13 | 13 | $910.00 | $793.00 | 87.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 13 | 13 | $5,655 | $743.79 | 13.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 24 | 24 | $1,080 | $416.05 | 38.5% |
About Dr. Guillermo Cuna, M.D
Dr. Guillermo Cuna, M.D is a Family Medicine healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1124024047.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Guillermo Cuna, M.D has received a total of $5,682 in payments from pharmaceutical and medical device companies, with $345.33 received in 2020. These payments were reported across 290 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($5,657).
As a Medicare-enrolled provider, Cuna has provided services to 1,221 Medicare beneficiaries, totaling 2,058 services with total Medicare billing of $163,156. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Fort Myers, FL
- Active Since 06/24/2005
- Last Updated 03/24/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1124024047
Products in Payments
- FARXIGA (Drug) $958.27
- XARELTO (Drug) $509.74
- Ozempic (Drug) $404.98
- JARDIANCE (Drug) $343.12
- Trintellix (Drug) $299.72
- JANUVIA (Drug) $287.30
- INVOKANA (Drug) $283.95
- EUCRISA (Drug) $247.21
- TRULICITY (Drug) $168.67
- ANORO (Drug) $141.10
- Aimovig (Biological) $130.17
- BEVESPI AEROSPHERE (Drug) $125.00
- BREO (Drug) $103.79
- Victoza (Drug) $91.92
- TRINTELLIX (Drug) $91.31
- TRADJENTA (Drug) $87.75
- Tresiba (Drug) $84.76
- MYRBETRIQ (Drug) $83.19
- SHINGRIX (Biological) $80.83
- ADVAIR (Drug) $75.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Fort Myers
Dr. Shannon Greer, D.o, D.O
Family Medicine — Payments: $88,641
Family Medicine $88,641
Derek Dewitt, D.o, D.O
Family Medicine — Payments: $17,375
Family Medicine $17,375
Peter Lautenbach, Do, DO
Family Medicine — Payments: $12,437
Family Medicine $12,437
Dr. Frederick Burford, D.o, D.O
Family Medicine — Payments: $11,863
Family Medicine $11,863
Ms. Carmen Fernandez, D.o, D.O
Family Medicine — Payments: $9,756
Family Medicine $9,756
Dr. Rebekah Bernard, Md, MD
Family Medicine — Payments: $8,435
Family Medicine $8,435